U.S. Senate Subcommittee on Execuuve Reorganizat~on, 24, 25, 26, May 1966, Organization and Coordination of Federal Drug Research and Regulatory Progratns: LSD (Washington, D.C.: Government Print~ng Office, 1966) (hereafter cited as Federal LSD Research), pp. 139, 145, 155. Isis, 1997, 88: 87- received an infusion of irrational passion from the psychedelic crusaders and their enemies. . . . Twenty years after its introduction it was a pariah drug, scorned by the medical establishment and banned by the law."2 On the other hand, proponents of LSD have attributed the medical profession's opposition to the wire-pulling of the CIA or to doctors' fear of social change. Thus one account blasted an anti-LSD editorial by saying, " [Roy S.] Grinker cited no data to back up these rather serious charges. He cited no data for the simple reason that there were none-Sidney Cohen's 1960 study on adverse reactions was still unchallenged in the literature. What Grinker was doing was projecting his own professional bia~es."T o illuminate this debate, this article, based on new archival material and oral history interviews, analyzes Cohen's pioneering studies of the safety of LSD. Through this lens one can obtain a behind-the-scenes look at the tensions between physicians and intellectuals in defining LSD's meaning, plot the shift of LSD research from a scientific investigation into a cultural crusade, map the spread of LSD in the 1950s, and elucidate the medical profession's alarm over LSD, which led to government passage of tighter regulations of psychedelic drugs. Before Timothy Leary, who first took LSD in 1961, catapulted to the national scene by being fired from Harvard in 1963, Sidney Cohen had sounded the alarm that LSD was being abused and hurting people." THE MAKING OF A PSYCHOPHARMACOLOGIST Cohen came to LSD research with a strong background in pharmacology. Born in 1910, in New York City, he was one of seven children of a Lithuanian-Jewish shoe shop owner. He majored in pharmacology at City College of New York and Columbia University, then earned an M.D. in 1938 from the University of Bonn. During World War I1 he served in the Army Medical Corps in the South Pacific. After his discharge he took a residency at the Wadsworth Veterans Administration Hospital in Los Angeles, adjacent to the University of California, Los Angeles, and then accepted a position as an internist across the street at the Brentwood VA Hospital for mentally ill ~ervicemen.~ When Wadsworth and Brentwood affiliated with the new UCLA School of Medicine, Cohen became an assistant clinical professor, supervising interns and graduate students. Handsome and prematurely gray, he gained a reputation as a popular teacher with an infectious enthusiasm for research. (See Figure 1 . ) Cohen's interest in mental illness stemmed from his responsibilities at Brentwood. He puzzled over how to diagnose the physical ailments of his mute, catatonic, irrational patients. As he sought to explore the patients' physical symptoms, his first publications dealt
The first notice of Leary in the Reader's Guide to Periodical Literature is "LSD and All That," Time, 29 Mar. 1963 , pp. 72-73. Dorothv Cohen interview. 27 Feb.'1993 . Unless otherwise noted, all interviews were conducted by the author and all intehiew tapes and notes are in his possession. I am grateful to Cohen's daughter for providing me with information about her father, photographs, and access to his personal papers (hereafter cited as Cohen Papers).
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STEVEN J. NOVAK Flgure 1. Sidney Cohen in 1957. (Courtesy of Dorothy Cohen.) with diagnostic physical probes. Next he shifted toward biochemistry, publishing a case study on Cushing's syndrome in which he warned that the overproduction of adrenal cortical steroids that caused the disease was often undetectable and that patients should be given frequent "urinalysis, blood chemistry studies, renal function and glucose tolerance test^."Ĉ ohen grew intrigued by the mental and behavioral side effects of diseases and drugs.
In 1951, after an accidental overdose left a patient "acutely psychotic" and paranoid, he undertook a study of the effects of Banthine. Cohen also wrote a survey of toxic psychoses, temporary breaks with reality due to disruption of the body's biochemical homeostasis. He observed that toxic psychoses were "unexpected and almost unpredictable" and could result in "catatonic stupor, manic excitement, paranoid agitation, or a vivid hallucinosis." His toxic psychosis research led to his interest in LSD. In his 1953 survey he first mentioned other investigators' research on LSD, a drug that at this time he said caused "a transient psychosis in all subjects."' 
LSD BEFORE LEARY

LSD AS A MODEL PSYCHOSIS
LSD-25, lysergic acid diethylamide, was a new investigational drug available only to physicians for research purposes. It had been synthesized in 1938 at the Basel, Switzerland, laboratories of Sandoz Pharmaceuticals, by the chemist Albert Hofmann. Hofmann discovered its mind-altering properties in 1943 when he accidentally ingested a minute quantity and thought he was going mad. For years psychiatrists had searched for a chemical cause of insanity but had failed to find measurable abnormalities in the blood or urine of psychotics. What made Hofmann's discovery so exciting was that LSD worked in almost infinitesimal doses. Other drugs were measured in milligrams, thousandths of a gram, but LSD was measured in micrograms, millionths of a gram. Hoping that LSD might have clinical applications, Sandoz brought it to the attention of scientists, and samples reached the United States in the fall of 1949.8 Though the idea that LSD per se caused insanity was soon abandoned, researchers began to experiment with LSD to induce a model psychosis in subjects. They sought to use it as a means of temporarily replicating the effects of mental illness, as a so-called psychotomimetic, like hashish and mescaline, which psychiatrists had previously employed. By the mid 1950s, LSD research was being conducted in major American medical centers as well as in Canada, England, and Europe. In the background of this research was the alleged "brainwashing" of American prisoners during the Korean War. Popular accounts of brainwashing claimed that "some drug or 'lie serum' may possibly be used to speed up collap~e."~To determine whether LSD might be a truth serum or a form of chemical warfare, the Central Intelligence Agency secretly began to fund LSD research in 1953 and the Army Chemical Corps started its own tests in 1955.1° Because LSD was originally perceived as hazardous, the subjects of the early experiments were often soldiers, mental patients, prisoners. conscientious objectors, animals, medical school staff members, and physicians themselves." A few early investigators refused to take LSD, while others who on pp. 813, 817. Cohen attributed his interest in LSD to his research on toxic psychosis; he is quoted in Harold A. Abramson, ed., The Use of LSD in Psychotherapy (New York: Macy Foundation, 1960) tried it said they experienced only unpleasant or inconsequential effects.12 To guard against untoward reactions, doctors conducted experiments in clinics and laboratories. Subjects were monitored by EEG machines and polygraphs, had their words tape-recorded, and were given lengthy psychological and intelligence tests.
Though reactions varied, the usual LSD session included visual illusions, luminous, intense colors, undulating lines and multiple images in geometric patterns; dissociation, loss of ego boundaries, distorted body image; an elongated sense of time; synesthesia-"seeing" sound or "hearing" sights; emotional lability, giggling and weeping, anxiety and detachment; and a tantalizing sense of portentousness or incompleteness. The question was what-if anything-these symptoms signified.
The early LSD researchers concluded that their subjects went through a temporary psychosis, most commonly categorized as schizophrenia or paranoia. Subjects performed poorly on tests, made perceptual errors, and exhibited loss of concentration and regressive behavior.13 Even the euphoria sometimes present was defined as manic and hebephrenic.14 Researchers had anticipated deleterious effects. The widely used questionnaire devised by the Harold A. Abramson lab in New York presented all of its questions in negative terms. May 25, 26, and 27, 1955, Princeton, N.J., ed. Harold A. Abramson (New York: Macy Foundation, 1956) Sci., 1954, 100:125-128, on p. 125; Bercel et al., "Model Psychoses Induced by LSD-25," pp. 588-618; and Rinkel, "Experimentally Induced Psychosis," p. 236. 
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Forty-eight percent of Abramson's subjects said they felt unsteady, 41 percent weak, 40 percent peculiar, 27 percent anxious, and 26 percent nauseous. By the mid 1950s, when this first wave of LSD research reached the public in popular magazines, undergoing the effects of LSD was portrayed as a harrowing experience.15
LSD AS A PSYCHEDELIC EXPERIENCE
That LSD produced a model psychosis was taken for granted when Cohen first took the drug on 12 October 1955. He expected to feel catatonic or paranoid, but instead, he wrote, "I was taken by surprise. This was no confused, disoriented delirium, but something quite different." His subsequent report described feeling an elevated peacefulness, as if "the problems and strivings, the worries and frustrations of everyday life vanished; in their place was a majestic, sunlit, heavenly inner quietude. . . .I seemed to have finally arrived at the contemplation of eternal truth." 16 Cohen immediately launched his own LSD experiments. He sponsored three doctoral dissertations by UCLA graduate students in psychology that measured the effects of LSD on eighty-one members of the academic c~mmunity.'~ The dissertations followed the standard model psychosis methodology of conducting extensive tests, and the results replicated prior studies: subjects showed impaired intellectual ability, lowered IQ, inability to concentrate, and breakdown of ego functioning. Afterward, they reported that under LSD they felt emptiness, loneliness, and isolation. Cohen was disappointed by these reactions, which differed from his own. At the 1959 Princeton LSD conference, he said, "Though we have been using the available measuring instruments, the check lists, the performance tests, the psychological batteries, and so forth, the core of the LSD situation remains in the dark, quite untouched by our activitie~."'T Rather than accept the dissertation findings as an accurate picture of the effects of LSD, Cohen took the crucial step of altering his approach. He shifted the focus of his LSD research to men of letters. The idea of filtering LSD reports through refined psyches was suggested by the Canadian psychiatrist Humphry Osmond, who first gave mescaline to Aldous Huxley. At a 1956 conference, Osmond said that one of the problems with LSD research was that there was a "dearth of subjects skilled in self-ob~ervation."'H oping for more articulate reports, Cohen tried LSD on psychoanalysts, supposed experts on the unconscious, but they either blocked the drug effects or had bad reactions. Next he turned to his friend Gerald Heard, an English expatriate freelance writer whose special interests were mysticism and popular science. In 1957 Heard wrote a friend that he was one of the "human guinea pigs in the lysergic acid research." He described the effect as "a shift of consciousness" that was "so clearly similar to the accounts given by the mystics that none of us feel able to deny that this is in fact the experience which we Cohen also collaborated with Heard's friend Aldous Huxley, whom he met in late 1955. The famous author of Brave New World was the literary lion of Los Angeles, where he had settled in 1937 to write for Holly~ood.~' (See Figure 2 .) Owing to his near blindness, which dated from his youth, Huxley was unable to engage in active scientific research himself, but he compensated by cultivating his talents as a conversationalist and stylist. Rather than explore the broad paths of thought, he searched the odd byways-hypnotism, ESP, flying saucers, and reincarnation.
Long before Cohen met him, on 4 May 1953, Huxley had persuaded Osmond to give him a dose of mescaline, an experience that inspired him to write The Doors of Perception (1954) and Heaven and Hell (1956) . In both books Huxley mentioned LSD, though he did not actually try it till December 1955, after the books were written.22 Huxley redefined taking mescaline and LSD as a mystical religious experience. He claimed that these drugs allowed one to transcend the mundane world and enter the elevated state of consciousness usually reserved to poets, artists, and saints.
A few medical researchers questioned the validity of Huxley's account. Louis Lasagna To make the public receptive to mescaline and LSD, Huxley sought to provide a new label for the drugs: "It will give that elixir a bad name if it continues to be associated, in the public mind, with schizophrenia symptoms. People will think they are going mad, when in fact they are beginning, when they take it, to go sane." With Huxley's help, Osmond discarded his former term for describing these experiences-hallucinogenic, which connoted mental illness-and in 1956 coined the word psychedelic, which signified "mind-manifesting." Osmond introduced the new term at a 1956 conference at which he declared that LSD's effects were not a model psychosis but, rather, a psychedelic experience. "For myself," he said, "my experiences with these substances have been the most strange, most awesome, and among the most beautiful things. . . . These are not escapes from but enlargements, burgeonings of reality."25 That physicians like Osmond and Cohen would turn to nonmedical thinkers like Huxley and Heard was partly due to psychiatry's lack of an adequate model of mental illness, such as the germ theory provided for infectious disease. At first Cohen deferred to these prominent intellectuals. He treated them more as collaborators than as subjects and trusted them with samples of LSD for self-experiments and to administer to others. He wrote in a posthumous tribute to Heard, "We learned from Gerald that, just as in some psychological experiments animals are inappropriate test subjects, so in certain experiments with the psychedelics ordinary men are inadequate subjects. . . . He was a skilled, articulate observer in entering into an indescribable, surging state, which could fragment some with its intensity and divert others with its entertaining visual display^."^L
SD AND PSYCHOTHERAPY
Besides turning to intellectuals, Cohen revised the reasons for giving LSD. He explored whether LSD might have a helpful effect in facilitating psychotherapy, curing alcoholism, and enhancing creativity. To test LSD in psychotherapy, he collaborated with Betty Eisner, a recent UCLA doctorate in psychology. The rationale underlying their study was the Freudian belief that the roots of maladjustment lay in trauma buried in the unconscious. Where Freud had used talk therapy to explore the unconscious, other psychiatrists tried to enter the subconscious by injecting their patients with drugs such as sodium amytal or causing them to inhale carbon dio~ide.~' This so-called narcoanalysis was much discussed in the 1950s. An English psychiatrist described LSD as "assisting the unconscious to reveal its secrets," though other psychiatrists were skeptical of its therapeutic potential.28 Cohen and Eisner sought to maximize LSD's potential by taming its terror. Cohen wrote Osmond, "We are going to study how and whether the LSD experience can be more 'healing.' . . . We are putting Betty Eisner to work on the development of an optimal technique and will see whether anything comes of it." They consulted with A1 Hubbard, who first gave Huxley LSD and was using the drug in therapy in Canada. Hubbard was a mysterious figure, a charismatic, flamboyant entrepreneur with an extravagant lifestyle.29 Huxley and the Canadian researchers hoped that Hubbard would finance LSD research, not realizing that he planned to make his fortune with the drug. Though not even a college graduate, Hubbard purchased a diploma-mill Ph.D., wore an Aesculapian tiepin, and, on his own, administered LSD, even though he was not a physician. To soften LSD's harsh effects, Eisner and Hubbard devised techniques such as starting with low doses, providing a domestic setting for "treatment," and establishing close rapport with patients before giving them the drug. Cohen was impressed by Hubbard's techniques but suspected that much of the effect was due to suggestion, which might not produce lasting improvement. He also worried that if subjects were merely reacting to the setting, the drug itself was not exposing their u n c o n s c i ~ u s . ~ Ĩ n April 1957 Cohen and Eisner began giving LSD to psychotherapy patients. Over the next year and a half they treated twenty-two patients suffering from minor personality disorders. Unlike the model psychosis subjects, these patients expected that the drug would be therapeutic. Aware that evaluating therapy was subjective, Cohen and Eisner waited six months and then measured progress in the patients by behavioral criteria such as holding a job, sustaining a relationship, or giving up drinking. Working with these criteria, they reported a remarkable 73 percent improvement rate.
Their 
In his research Ditman gave LSD to seventy subjects. They received a single dose, without therapy, in a nonthreatening setting. Later, subjects rated three hundred card-sort statements. Ditman's first published finding was that LSD did not resemble the DTs. Whereas the DTs were marked by "anxiety, horror, depression, irritation, and paranoid Mental Dis., 1958, 127:528-539; and Betty Eisner to Reilley, 13 Feb. 1957 , 20 Jan. 1993 
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98 LSD BEFORE LEARY thoughts," the LSD experience had been "typified by euphoria, humor, relaxation, and a nebulous sense of ~onderment."~Ñ ext Ditman published a full breakdown of the card-sort responses. When subjects were asked, "Looking back on your LSD experience, how does it look to you now?"72 percent replied "a very pleasant experience," 66 percent "something I want to try again," and 66 percent "an experience of great beauty."36 One would hardly think that this was the same drug used in the model psychosis research of the early 1950s. LSD was like a barometer measuring cultural change and preconceptions, and its subjective "meaning" was a social construct. Obviously, Ditman's subjects were having what Huxley had called a "psychedelic" experience.
By the end of the 1950s LSD was known as a miracle cure for alcoholism. In 1960 Huxley lectured at Harvard and met Leary, whom he regaled with LSD anecdotes: "Humphry Osmond curing alcoholics in Saskatchewan. Keith Ditman's plans to clean out Skid Row in Los Angeles." Likewise, the psychologist Abraham Maslow pointed to LSD research on alcoholics as proof of the therapeutic value of "peak experience~."~'
The third new area of LSD research was testing its effect on the creative process. Model psychosis researchers had occasionally given mescaline or LSD to artists in order to track their mental deterioration, but psychedelic researchers like Huxley expected the drugs to enhance creativit~.~~ The prevailing aesthetic of the day traced the origins of creativity to the unconscious. The reason people failed to be creative was that their conscious minds were encrusted by dull conventionality. Artists romanticized people who supposedly lived close to the unconscious~hildren, natives, outcasts, and the mentally
The popular equation of art and neurosis was so strong that in the 1950s therapists complained that patients resisted getting well because of the "culturally noxious assumption . . . that one 39 John D. Graham, one of the apostles of modernism, wrote that "the unconscious mind is the creative factor and the source and the storehouse of power and of all knowledge, past and future. The conscious mind is but a critical factor and clearing house. Most people lose access to their unconscious at about the age of seven. By this age all repressions, ancestral and individual, have been established and free access to the source of all power has been closed. This closure is sometimes temporarily relaxed by such expedients as danger or nervous strain, alcohol, insanity, and inspiration. Among primitive people, children, and geniuses this free access to the power of the unconscious exists in a greater or lesser degree": John D. must be sick to be creative." A University of Chicago physiologist wrote that "from the young, the naive, the dreaming, the drug users, come a great spate of fresh imagining~."~C ohen never published his findings regarding creativity, but he accepted for a time that LSD stimulated originality. The major figure testing LSD on artists was the psychiatrist Oscar Janiger, who often shared office space with Cohen. Janiger tested LSD on more than a hundred painters, writers, and composers between 1958 and 1962 and on a thousand subjects overall. Though his plan had been to test a cross-section of the population, "the artists began to come in a flood. Then I realized my demographic structure was going to be shot out the window," forcing him to turn artists away.4i
To some psychiatrists, the fantastic claims being made for LSD seemed incredible. Investigators in the rest of the nation wondered why their subjects had not had transcendental experiences. They charged that West Coast investigators were biased in favor of LSD. Louis Jolyon West asserted that "either LSD is the most phenomenal drug ever introduced into treatment in psychiatry, or else the results were evaluated by criteria imposed by enthusiastic, if not positively prejudiced, people." Since it seemed "unlikely that subjects on the West Coast are organically different from those on the East Coast," Jonathan 0. Cole hypothesized that the differences must have resulted from "a therapistinduced mystical experience similar to religious conversi~n."~P
OPULARIZING LSD
In 1959, as LSD was at its peak of medical acceptance, Cohen's antennae began to pick up danger signs. One disturbing trend was that researchers were growing lax in controlling the drug. They began to share LSD in their homes with friends. A 1958 article on experiments at the nearby Long Beach VA Hospital let slip that researchers were having "LSD- 
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Cohen was also concerned that LSD research was being mixed with pseudoscience. Almost from the start, he and Eisner clashed about interpreting their therapy results. "I think that the material we have been getting makes him uncomfortable," she wrote. "In fact, he has said as much." By "material" Eisner meant the vivid sense subjects sometimes had that they were revisiting ancient Egypt, India, or Greece. Huxley, Heard, Hubbard, Eisner, and other researchers considered these impressions to be actual memories of past lives-proof of rein~amation.~~ What brought reincarnation to mind was the best-selling book The Search for Bridey Murphy (1956) , in which an amateur hypnotist claimed to have uncovered the prior identities of his subject. Heard served as a consultant on the book and advised the author that the memories were a u t h e n t i ~ . ~ Ĩ n addition to reincarnation, pseudoscientists claimed that LSD facilitated extrasensory perception. Huxley and Heard popularized paranormal psychology and published their accounts of LSD experiences in journals of psychical research. Eileen Garrett, founder of the Parapsychology Foundation, experimented with LSD in the 1950s and funded LSD re~earch.~Werfoundation sponsored conferences on psychedelics and ESP in New York City in 1958 and in France in 1959. Insofar as ESP, like reincarnation, lacked academic respectability, Cohen realized that being coupled with ESP would lessen LSD's credibility. He hoped to find a "middle ground between scientific positivism, on the one hand, and "the Huxleys and Heards, . . .the Hubbards and witch doctors and the medicine men," on the other. LSD, he wrote, had "opened a door from which we must not retreat merely because we feel uncomfortably unscientific at the thre~hold."~Ỹ et Cohen did feel "uncomfortably unscientific." In 1960 he wrote his sponsor, "I deplore some of the fringy goings on with this group of drugs." By then he had distanced himself from some of his associates. He first rejected Hubbard. To gain credibility, Hubbard had created a mock institute called the Commission for the Study of Creative Intelligence. Huxley and Heard were board members, and Hubbard asked Cohen to join. In If you give it to someone for philosophic or religious reasons, you are still prescribing a drug."49 Only physicians were by law authorized to experiment with drugs, especially investigational drugs.
Next Cohen broke off from Eisner. At the end of their psychotherapy experiment she wanted to start another round of patients, but he begged off. Actually, he planned to launch a more strictly controlled study, but he confided that "it does not seem to me that Betty is the ideal therapist for an investigation of this sort. Her personal investment in the success of LSD therapy tends to reduce the validity of her results."50
Cohen even began to keep Heard at arm's length. They had written drafts of a book on LSD together, entitled "Journey into Consciousness," and submitted it for publication. When the manuscript was rejected, Heard hoped to revise it, planning to stress the beneficial effects of LSD, but Cohen ended the collaboration. According to Heard, Cohen "felt it would be wiser for him not to be identified with so positive an approach. ...He feels any reference that would go beyond recording the psychotomimetic side of the medicament's action is 'unscientific.' "Cohen not only retreated from their joint projects but even refused to write an introduction for Heard's proposed volume, explaining that Heard's manuscript was "intemperate in its hope for LSD." When Cohen's book The Beyond Within: The LSD Story appeared, Heard chided him for playing "public prose~utor."~W hile Cohen grew nervous about the excesses of LSD zealots, a second wave of publicity presented LSD effects not as a model psychosis but as a panacea. Cohen himself took part in the publicity. He served as technical consultant on a 1957 television special entitled The Lonely World. He wrote a friend, "It is about LSD. . . . I'm not too proud about the story, but it is not completely incredible. It's the old compromise between fact and drama." The media's tendency to exaggerate plagued LSD researchers. Later that year Cohen served as an advisor on the eight-part Focus on Sanity, which again brought LSD to television. As the audience watched one of Cohen's attractive female subjects undergoing an LSD experience, Heard told viewers, "For most .. . it's an outstanding event in their lives." On 12 March 1958 Cohen gave LSD to Paul Saltman, a young University of Southern California biochemist, whose reaction was filmed for local television. Saltman hammed it up for the journalists, exclaiming, "It's wild, man, (See Figure 3.) presented their LSD therapy findings at the American Medical Association convention in San Francisco, their talk caused such a stir that it led to a TV appearance and a front-page story. The San Francisco Chronicle reported that five LSD treatments, at a dollar per session, were more effective than "the standard sessions of psychoanalysis, which often require hundreds or thousands of hours, and many thousands of dollars." Traditional therapists were appalled by the account. Eisner wrote that while being on TV had been "fun," the newspaper's "garbled" article had made her "ambivalent about publicity." That fall, Ditman gave reporters a glowing account of the UCLA Alcoholism ~esearch Clinic. "Many subjects who have undergone LSD experiences think highly of the beneficial effects of the drug," he declared. Janiger lectured frequently on LSD to art institutes. A newspaper declared, "Most exciting finding: apparently all of us have a creative faculty, and LSD shows there may be ways to unlock it at will."51 The biggest splash came in 1959, when Cary Grant told Hollywood gossip columnist Joe Hyams that he had taken LSD over sixty times in therapy since 1958. Grant bragged that because he took LSD "young have never before been so attracted to me."54 As might be expected, people clamored for the drug. Hyams recalled, "After my series came out, the phone began to ring wildly. Friends wanted to know where they could get the drug. Psychiatrists called, complaining their patients were now begging them for LSD. . . .In all, I got close to eight hundred letters." Historical accounts of media coverage of LSD have missed this pre-1960s publi~ity.~~ Obviously, by the end of the 1950s the public was well aware of LSD.
In addition to his concern about overzealous LSD apostles and widespread publicity, Cohen shared the medical profession's worries about the problems created for medical ethics by exploding pharmaceutical research. Physicians feared that drug companies were introducing too many new drugs, too fast, turning doctors into drug company advance men and their patients into guinea pigs.56 Participants in a 1956 conference concluded that, and Harry Nelson interview, 16 Nov. 1991. Three weeks before Saltman's filmed LSD experience a UCLA professor of pharmacy had announced that LSD "does make everything seem beautiful": "Hallucinatory Drugs Defended by Doctor," Los Angeles Tirnes, 21 Feb. 1958, Sec. 1, p. 14.
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LSD BEFORE LEARY although physicians enjoyed legal immunity and insurance coverage for mishaps that occurred in the course of treating patients, "in giving drugs to volunteers the physician has no such legal protection. The death of a volunteer caused by taking an experimental drug would legally be homicide." Fearing lawsuits, at the 1959 Princeton conference Paul Hoch advised LSD researchers "to be very much aware of the legal implications of many of these things we are doing." In fact, psychiatric experiments entailed unknown risks. That same year psychiatrists conducting experiments on sleep deprivation and sensory isolation, which produced LSD-like hallucinations, discovered that these experiences could cause mental breakdown^.^Û nfortunately, just as the safety of LSD was becoming an issue, the drug was spreading into the undergraduate population. On 20 March 1959 Los Angeles newspapers carried a front-page story about the drug death of a freshman at the University of Redlands, eighty miles east of Los Angeles. The police investigation showed that he and five classmates had been experimenting with drugs, among them mescaline and LSD, in his dorm room. Closer to home, that same spring the UCLA biochemist Clara Szego kept two of her students from taking part in a campus LSD experiment. She had tested LSD on rats and recalls, "It was perfectly clear to me that this was no innocuous little substance that you could recover from."58 She forced the investigators to stop their experiments.
INVESTIGATING THE SAFETY OF LSD
Almost a decade after LSD research began in the United States, Cohen took the unusual step of launching an investigation into the drug's safety. He explained his motivation in a cover letter: "A survey of this sort seems desirable at this time because reports of undesirable and unexpected reactions to lysergic acid diethylamide are not finding their way into the literature. Since it is coming into more widespread use, it may be possible, through an analysis of the collected data, to avoid some of the untoward events that might otherwise occur." In February 1959 he sent a questionnaire to sixty-two LSD researchers, forty-four of whom replied. He asked whether any of their subjects had died, committed suicide, or suffered mental breakdowns or other serious side effects. Their responses provided demographic data about authorized LSD and mescaline use to that date. Researchers reported having administered the drugs over twenty-five thousand times to almost five thousand individuals. Though there had been occasional panic attacks, ten prolonged psychotic reactions, and a few flashbacks, no one had died by being poisoned by the drug.59 Arch. Neurol. Psychiat., 1959, 8I:348-359; and Bernard Bressler et al., " Research in Human Subjects and the Artificial Traumatic Neurosis: Where Does Our Responsibility Lie?" Amer. J. Psychiat., 1959, lI6:522-526. 58 Los Angeles Times, 20 Mar. 1959, Sec. 1, pp. 1, 16; Los Angeles Evening Mirror News, 20 Mar. 1959, Sec. 1, p. 4; Los Angeles Examiner, 22 Mar. 1959, Sec. 1, p. 28 Cohen to Oscar Janiger, 6 Feb. 1959, Hofmann Foundation. For Cohen' s report of his findings see Sidney Cohen, "Lysergic Acid Diethylamide: Side Effects and Complications," J. Nervous Mental Dis., 1960, I30:30-39 .
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A key statistic was suicides. Frank Fremont-Smith said in 1959, "We are all worried that someone might commit suicide after taking the drug." Cohen had learned of five possible LSD suicides but concluded that only two of these had been "directly due to LSD."60 In his published report, he calculated that the suicide rate of LSD subjects was 0.4/1,000-two suicides among five thousand cases. On the basis of this figure, he concluded that complications were "surprisingly infrequent" and that, in the hands of experimental clinicians, LSD and mescaline were "safe." Nevertheless, Cohen's article offered much advice on how to screen people who should not take the drug and on how doctors could terminate an LSD session gone awry.
LSD activists read Cohen's study as if it were a ringing endorsement. His statistic of 0.4 suicides per one thousand subjects was widely cited in subsequent years. A 1964 study quoted Cohen's figure as proof that LSD was "exceptionally safe." A model legal release form for LSD experiments offered Cohen's 1960 calculations as the only data about risksvital information for informed consent. In 1966 Leary cited the study in his congressional testimony . 61 The trouble was that Cohen's study was tentative. The data were vague because he only asked investigators for approximate numbers and then rounded them off. The data were guesswork because not a single lab had carried out a follow-up of its subjects. Cohen acknowledged that his study was "doubtless incomplete" and that he suspected "serious complications" might have gone unreported because of investigators' "guilt feelings."62 Eighteen researchers failed to reply to the questionnaire, and some key labs had withheld vital information. Cohen was not informed that in 1952 a patient at the Massachusetts Mental Health Center had committed suicide within hours of being injected with LSD.63 He did not know of the Hoch patient who died in 1953 after being injected with a mescaline derivative. The CIA had successfully covered up the 1953 suicide of one of its subjects. An expert later speculated that if Cohen had been aware of the CIA suicide he might have reached different conclusion^.^B ut Cohen did not close his investigation in 1960. No sooner was the ink dry on his article than he began to obtain new data, especially on abuses by unqualified therapists that had caused adverse patient reactions. Therapists were drawn to LSD partly because it broke down patient defenses but also because it was lucrative. Although Sandoz Pharmaceuticals gave the drug away, therapists charged up to $500 for a session. As an investigational drug, LSD was supposed to be used exclusively for research, but to get around this rule therapists simply tabulated and wrote up their results--or said they planned to. 
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LSD BEFORE LEARY published a paper in which they reported giving LSD 690 times to 110 patients, who showed a 69 percent improvement rate. A second group offering LSD therapy and research was the Menlo Park Foundation for Advanced Study, which operated both in the Bay Area and in Southern Calif~rnia.~~ It charged $600 per treatment, and its founders dreamed of opening a string of LSD clinics across the nation. By the early 1960s at least a dozen Los Angeles psychologists were using LSD in therapy, including Huxley's wife Laura. Several incidents occurred, though a veil of silence hides many of the worst excesses. An LSD therapy handbook written by Canadian psychologists recommended that therapists take LSD along with patients to improve rapport, and some Southern California psychologists who took the advice became involved in sexual activity with their patients and were charged with sexual abuse. In 1962 a middle-aged Long Beach man filed a $500,000 damage suit against his clergyman, the president of the Menlo Park Foundation, and several others on the grounds that they had enticed him to take LSD, a "dangerous" drug, which they were "unqualified to administer. After taking LSD he had suffered depression, attempted suicide, and ended up in a mental in~titution.~~ By 1963 a number of local LSD investigators who were heavy users themselves had fallen afoul of legal and medical authorities; some had even been hospitalized. Cohen was bitter about the excesses of LSD psychotherapists. He charged that LSD therapists "have included an excessively large proportion of psychopathic individual^."^Ĉ ohen's only connection to these for-profit LSD therapists was in treating their failures. One case in particular crystallized his concern. A forty-year-old woman who had undergone eight LSD treatments in Honolulu administered by Dr. William E. Stevens attempted to commit suicide in 1961 and ended up at the UCLA Hospital. In taking her history, Cohen discovered a painfully unstable life, including child abuse, murdered parents, prostitution, illegitimate children, divorces, suicide attempts, and electroshock treatments. He thought LSD was contraindicated in her case and upbraided Stevens: "I wondered why uncovering therapy was given this recently psychotic unstable woman. . . .Oddly enough, she wants LSD. I told her that she wanted magic and that this would be very risky. . . . I think she should be considered an LSD failure. "68 In his defense, Stevens explained that this woman had suffered one of only two known disastrous experiences in the four hundred LSD sessions he had administered so far, though he told Cohen of other abuses in Hawaii. In reply, Cohen acknowledged Los Angeles's own problems: "We, too, have our share of hair-raising LSD operations. Only today Keith [Ditman] and I saw a woman who had a panicky dissociated state following extensive
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108 LSD BEFORE LEARY United States. Even before the thalidomide crisis broke, LSD researchers had been warned that they should stop giving the drug to pregnant women. In the medical community, LSD and thalidomide were linked. In Canada a new regulatory category of drugs was created, Schedule H, which could be neither sold nor distributed, and thalidomide and LSD were the first drugs placed on the list.73
The thalidomide crisis forced Congress to pass tougher regulatory controls over investigational drugs. Since December 1959, Senator Estes Kefauver had been conducting hearings on drug company price fixing. Suddenly, after the thalidomide scare, his committee was in the spotlight. In hearings held in August 1962, Senator Jacob Javits was amazed to learn that physicians could try out unproven drugs on patients without warning them that they were being tested. The head of the Food and Drug Administration, George P. Lamck, had to admit that, as the law then stood, "that is up to the physician." On 10 October 1962, Congress passed the Kefauver-Harris Drug Amendments, which went into effect in January 1963. Henceforth the FDA had to give prior approval for all testing of new investigational drugs, and such drugs would be authorized for sale only if they had been proven both safe and efficacious in curing some human ailment.74
The FDA and the Federal Bureau of Narcotics had been caught napping by this new outbreak of drug use. The FDA's first investigations of LSD abuse began in 1961, in Southern California, where early "reports of misuse" focused on "physicians and psychologists who were not authorized to use the drug."75 NO one knows who tipped off the FDA, but in 1962 agents raided several Los Angeles therapists and seized their LSD supplies. Sandoz Pharmaceuticals took the opportunity provided by the new FDA regulations to cut off the supply of LSD to marginal investigator^.^^ In 1963 Sandoz restricted LSD to researchers connected to the National Institute of Mental Health, state commissioners of mental health, or the VA, which cut the number from a couple of hundred to only seventy. But it was too late to stop the spread of LSD. In early 1963 Leary was fired from Harvard and launched his crusade to have the nation's youth "turn on, tune in, and drop out." Leary gained so much notoriety that we forget that the crackdown on LSD began before his escapades.77 
CONCLUSION
The introduction to this article showed that the historiography of the psychedelic drug movement starts with the assumption that Cohen proved the safety of LSD in 1960 and then tries to explain why, nevertheless, the medical profession and the government turned against the drug. This article argues, on the contrary, that Cohen's study arose out of his concerns about its safety, that the study was admittedly incomplete and inconclusive, and that Cohen reversed himself only two years later. This interpretation sees medical opposition to LSD in the 1960s as due not to secret CIA conspiracies or to fear of the counterculture but to valid health concerns. The medical profession's rejection of LSD was not the result of its subservience to the government; rather, government restrictions on LSD followed pressure from physicians. The intrusion of "strangers at the bedside," as David Rothman has called increased governmental regulation of American medicine, was justified in the case of LSD research.79
